<qa>  What drug is used to treat MCL patients?Phase II will find out the effects, good andor bad, of ixazomib in combination with ibrutinib. In Phase II, patients will be separated into 2 groups, patients who have never received ibrutinib and patients who have received ibrutinib. This study is designed to examine the effectiveness of this drug in treating patients with MCL. 